CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing
- PhysioMimix NASH assay used to provide human-relevant data on compound efficacy for Inipharm’s lead candidate, INI-822
- Submission represents first example of an OOC provider’s data supporting clinical progression of a drug for metabolic, fibrotic liver disease